Get started
Author

Sarah Naomi Bolz

PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
2021 · Melissa F Adasme, Katja L Linnemann, et al. · Nucleic Acids Research · 2,123
PDF
PLIP 2025: introducing protein–protein interactions to the protein–ligand interaction profiler
2025 · Philipp Schake, Sarah Naomi Bolz, et al. · Nucleic Acids Research · 414
PDF
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
2020 · Daniele Parisi, Melissa F. Adasme, et al. · Computational and Structural Biotechnology Journal · 128
PDF
Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes
2021 · Sarah Naomi Bolz, Melissa F. Adasme, et al. · Journal of Chemical Information and Modeling · 110
SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2
2020 · Lisa von Wenserski, Christoph Schultheiß, et al. · Leukemia · 44
PDF
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
2020 · Melissa F. Adasme, Sarah Naomi Bolz, et al. · International Journal of Molecular Sciences · 35
PDF
Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants
2021 · Ali Al-Fatlawi, Negin Malekian, et al. · Cancers · 21
PDF
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor
2021 · Sarah Naomi Bolz, Sebastian Salentin, et al. · Computational and Structural Biotechnology Journal · 13
An improved high cell density cultivation—iHCDC—strategy for leucine auxotrophic Escherichia coli K12 ER2507
2017 · Björn Beckmann, Dorothea Hohmann, et al. · Engineering in Life Sciences · 12
PDF
Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances
2023 · Sarah Naomi Bolz, Michael Schroeder · Expert Opinion on Drug Discovery · 10
The structural basis of drugs targeting protein–protein interactions uncovered with the protein–ligand interaction profiler PLIP
2025 · Sarah Naomi Bolz, Philipp Schake, et al. · Expert Opinion on Drug Discovery · 6
Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
2022 · Melissa F. Adasme, Sarah Naomi Bolz, et al. · Journal of Cheminformatics · 6
PDF
The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemia
2018 · Simon Schliffke, Sophia Buhs, et al. · Blood · 3
Much ado about nothing: modeling amino acid replacement with predicted protein structures
2026 · Lukas Buschmann, Sarah Naomi Bolz, et al. · Bioinformatics · 1
AlphaFold Substituiton Matrix
2026 · Buschmann, Lukas, Bolz, Sarah Naomi, et al. · Zenodo (CERN European Organization for Nuclear Research)
Additional file 2 of Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
2022 · Adasme, Melissa F., Bolz, Sarah Naomi, et al. · Figshare
Additional file 1 of Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
2022 · Adasme, Melissa F., Bolz, Sarah Naomi, et al. · Figshare
Additional file 3 of Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
2022 · Adasme, Melissa F., Bolz, Sarah Naomi, et al. · Figshare
Works count: 23
Citation count: 2,926
H-index: 10
I10-index: 10
Year
Topic
Type